95 related articles for article (PubMed ID: 6114844)
1. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
Schöffling K; Hillebrand I
Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
[No Abstract] [Full Text] [Related]
2. Therapeutic potential of alpha-glucosidase-inhibitors.
Fölsch UR
Hepatogastroenterology; 1982 Apr; 29(2):47-8. PubMed ID: 7044933
[No Abstract] [Full Text] [Related]
3. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
Hayakawa T; Noda A; Kondo T; Okumura N
Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
[No Abstract] [Full Text] [Related]
4. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
[TBL] [Abstract][Full Text] [Related]
5. Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus.
Dimitriadis G; Karaiskos C; Raptis S
Horm Metab Res; 1986 Apr; 18(4):253-5. PubMed ID: 3519413
[TBL] [Abstract][Full Text] [Related]
6. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
Seifarth C; Bergmann J; Holst JJ; Ritzel R; Schmiegel W; Nauck MA
Diabet Med; 1998 Jun; 15(6):485-91. PubMed ID: 9632123
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
Fölsch UR; Lembcke B
Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561
[No Abstract] [Full Text] [Related]
8. [Inhibitors of alpha-glucosidase].
Toeller M
Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331
[No Abstract] [Full Text] [Related]
9. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
Schwartzkopff W; Calder D
Med Welt; 1984 Feb; 35(6):169-74. PubMed ID: 6369065
[No Abstract] [Full Text] [Related]
10. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle].
Drent ML; van der Veen EA
Ned Tijdschr Geneeskd; 1992 Feb; 136(7):308-10. PubMed ID: 1538796
[No Abstract] [Full Text] [Related]
11. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
12. A review of the safety and efficacy of acarbose in diabetes mellitus.
Yee HS; Fong NT
Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
[TBL] [Abstract][Full Text] [Related]
14. alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
Dimitriadis G; Raptis S
Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691
[No Abstract] [Full Text] [Related]
15. Alpha-glucosidase inhibitors in diabetes. Introduction.
Kruseman AC; Sels JP; Wolffenbuttel BH
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():1. PubMed ID: 8001619
[No Abstract] [Full Text] [Related]
16. [New, in Austria registered specialty drugs. Glucobay (acarbose)].
Sturm M
Wien Klin Wochenschr; 1992; 104(11):329-36. PubMed ID: 1621396
[No Abstract] [Full Text] [Related]
17. Efficacy of acarbose as monotherapy in NIDDM patients.
Deerochanawong C; Serirat S; Kornthong P
J Med Assoc Thai; 1996 Feb; 79(2):69-75. PubMed ID: 8868016
[TBL] [Abstract][Full Text] [Related]
18. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
Dimitriadis GD; Tessari P; Go VL; Gerich JE
Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
[TBL] [Abstract][Full Text] [Related]
19. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
Gérard J; Luyckx AS; Lefebvre PJ
Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
[TBL] [Abstract][Full Text] [Related]
20. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
Welborn TA
Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
